Definitive Contract 75D30122C13330
- Not listed
- This is a $5,092,787.07 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is for COVID-19 research focused on critically ill children and does not have a set-aside designation. Boston Children's Hospital is a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical School. Through this contract, the hospital is...
- The Centers for Disease Control and Prevention, an agency of the Department of Health and Human Services, awarded a $9,990,604.91 firm fixed price definitive contract to Boston Children's Hospital for MIS-C in Children. As the prime contractor, Boston Children's Hospital will deliver services to investigate Multisystem Inflammatory Syndrome in Children (MIS-C), a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or...
- This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for influenza vaccine effectiveness for children in the United States. The contract has a firm fixed price of $1,939,144.49 and does not have a set-aside designation. Boston Children's Hospital is a pediatric teaching hospital and research center affiliated with Harvard Medical...
- The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for the project "OUTBREAKS NEAR ME AND MONITORING TRENDS IN HEALTHCARE UTILIZATION AND LABORATORY". The contract has a potential value of $491,152.00 and a completion date of January 11, 2023. Boston Children's Hospital is a pediatric teaching hospital and research...
- The Centers for Disease Control and Prevention (CDC) awarded a $35.97 million firm fixed-price definitive contract to The Children's Hospital Corporation (doing business as Boston Children's Hospital) on February 1, 2023, for development and delivery of a Community Finder Platform. The contract, which carries no set-aside designation, is scheduled for completion by July 31, 2025, with performance based in Boston, Massachusetts. Boston Children's Hospital, a premier pediatric medical research and...
- This is a Cost No Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit hospital and research center. The $13,579,975.18 contract is for the ADJUVANT DEVELOPMENT PROGRAM, with a period of performance through November 29, 2025. This contract is not set aside for small businesses. Boston Children's Hospital is a prolific recipient...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Children's Hospital Corporation (doing business as Boston Children's Hospital), a non-profit hospital and research institution. The $4,300,145.00 Firm Fixed Price contract is for the Vaccines Adjuvant Development Program in Infectious and Immune Mediated Diseases. The contract has an ultimate completion date of September 29, 2026. Boston Children's Hospital, which is...
- This federal contract award was made by the Office of the Assistant Secretary for Administration, a civilian agency, to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, valued at $94,999.05, is for services to improve the child core set of measures used by Medicaid and the Children's Health Insurance Program (CHIP). The contract does not have a set-aside designation. Boston Children's...
- This is a $7,530,482 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Children's Hospital Corporation (doing business as Boston Children's Hospital), a non-profit hospital and research center. The contract is for the Vaccine Adjuvant Discovery Program (VADP), which supports the identification and characterization of novel, effective, and safe vaccine adjuvants. The contract has no set-aside designation and is expected...
- This is a $889,592.00 delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Childrens Hospital Medical Center, a non-profit hospital and research center in Cincinnati, Ohio. The contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) program, which evaluates vaccine safety data and provides clinical expertise to support the Department of Health and Human Services' (HHS) vaccine safety monitoring efforts. Under this task order, Childrens Hospital...
This is a $24,899,418.92 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract is for a COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Vaccine Effectiveness (VE) study, with a period of performance ending on September 15, 2026. The contract does not have a set-aside designation. Boston Children's Hospital has extensive experience conducting clinical research, managing data, and collaborating with government agencies through prior federal contract and grant awards, including work with the National Institutes of Health, Department of Health and Human Services, and Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Supplemental Agreement for work within scope | $3.7m | 9/12/24 | |
| P00003 | Exercise an Option | $7.0m | 12/21/23 | |
| P00002 | Supplemental Agreement for work within scope | $1.5m | 5/9/23 | |
| P00001 | Exercise an Option | $5.2m | 2/2/23 | |
| Not listed | Not listed | $7.5m | 8/3/22 |